FHIR R4 RiskEvidenceSynthesis API

Overview

This asset is a component of MuleSoft Accelerator for Healthcare.

MuleSoft Accelerator for Healthcare enables healthcare providers to unlock critical patient data to build a patient 360 within Salesforce Health Cloud, faster and easier than ever before. The solution includes pre-built APIs, connectors, integration templates, and prescriptive end-to-end reference architecture to bring patient demographics information and COVID-19 test results from any EHR into Health Cloud using HL7 V2 or FHIR standards.

The solution also provides a library of United States Core Data for Interoperability (USCDI) and FHIR R4 resources to help healthcare developers adhere to interoperability needs and jumpstart the development of healthcare digital transformation initiatives.

Use case covered

The scope of the RiskEvidenceSynthesis resource is to describe the likelihood of an outcome in a population with an exposure where the risk estimate is derived from the combination of research studies. Risk estimates are not effects and do not represent a difference between exposure states. Expressing risk estimates is done throughout reporting of biomedical research, systematic reviews, and clinical reference across all disciplines. Risk estimates as a "synthesis" of research studies is a different concept for risk estimation than risk estimates for an individual person.
This resource is referenced by EffectEvidenceSynthesis

This API uses FHIR R4 RiskEvidenceSynthesis Library.

More information about FHIR R4 RiskEvidenceSynthesis specification can be found here.